We produced insertion mutants of herpes simplex virus (HSV) that contain two functional copies of genes encoding different forms of glycoprotein D (gD). These viruses have the gene for HSV type 2 (HSV-2) gD at the normal locus and the gene for HSV-1 gD inserted into the thymidine kinase locus. Results of immunoprecipitation experiments done with monoclonal antibodies revealed that both gD genes were expressed by these viruses, regardless of orientation of the inserted HSV-1 gD gene, and that maximal synthesis of both glycoproteins depended on viral DNA replication. This apparently normal expression of the inserted HSV-1 gD gene was from a DNA fragment (SauI fragment, 0.906 to 0.924 map units) containing nucleotide sequences extending from approximately 400 base pairs upstream of the 5' end of the gD mRNA to about 200 base pairs upstream of the 3' end. The glycoproteins expressed from both genes were incorporated into the surfaces of infected cells. Electrophoretic analyses of purified virions and neutralization studies suggest that both glycoproteins were also incorporated into virions. This nonpreferential utilization of both gene products makes these viruses ideal strains for the generation and characterization of a variety of mutations.
Glycoprotein D (gD) is one of several envelope glycoproteins specified by herpes simplex virus (HSV) (39) . The two serotypes of HSV (HSV-1 and HSV-2) produce related, but antigenically and structurally differentiable, forms of gD (1, 4, 6, 13, 29, 30, 35, 36, 42) . Little is known about the physiological role of this glycoprotein except that it can elicit the production of neutralizing antibodies (4, 30, 35, 42) , a property shared with other HSV glycoproteins, and that anti-gD antibodies can block virus-induced cell fusion (A. G. Noble, G. T.-Y. Lee, R. Sprague, M. L. Parish, and P. G. Spear, Virology, in press).
The gene for gD was mapped to the S component of HSV DNA by analyses of HSV-1 x HSV-2 recombinant viruses (23, 34) and, later, to a 2.9-kilobase (kb) Sacl fragment of HSV-1 DNA (Fig. 1 ) by selection and translation in vitro of gD mRNA (16, 44) . Nucleotide sequence determinations, coupled with construction of a fused gene that expresses a X cro-gD hybrid protein in bacteria, have permitted precise localization of the coding sequence for the gD polypeptide of HSV-1 (44) . The requirements for adjacent nucleotide sequences upstream and downstream of the coding sequence for gD to be expressed in productively infected cells have not previously been explored, although it has been shown that gD can be expressed from the BamHI J DNA fragment (0.89 to 0.93 map units) injected into oocytes (43) .
Insertion of appropriate HSV-1 DNA fragments into the thymidine kinase (TK) gene of a gC-HSV-1 mutant permitted us to monitor expression of gC from the inserted DNA sequences of selected thymidine arabinoside-resistant (AraTr) progeny and thereby to define the boundaries of the region necessary for expression of the gC polypeptide in productively infected cells (17) . In this report we describe a similar approach for identification of sequences necessary for expression of the gD polypeptide in productively infected cells. In the process we have also generated viruses that contain duplications of the gD gene. They express HSV-1 gD (gD-1) from the inserted DNA in the TK gene and HSV-2 gD (gD-2) from the normal genomic locus. We demonstrate expression and apparently normal regulation of both genes as well as utilization of both products in virion morphogenesis and transport to the cell surface. (24, 41) . We reversed the orientation of the Sacl fragment with respect to the TK gene to obtain the new plasmid pMG903. The gD-1 gene has been mapped to this SacI fragment (16, 44 (44) , only the one shown is present in HSV-1(F) DNA. Sequences homologous to uninterrupted TK mRNA are also indicated along with the direction of transcription (24, 41) . Recombination between either of the plasmids shown and strain lAl DNA resulted in the generation of insertion mutants that were AraTr. Abbreviations used for restriction endonucleases are: Ba, BamHI; Ec, EcoRI; Hn, Hindlll; Nr, NruI; Sa, Sacl.
HSV MUTANTS EXPRESSING TWO FORMS OF gD
man. An HSV-1 x HSV-2 recombinant virus, designated R5OBG13 (also obtained from B. Roizman) and isolated by Tognon et al. (40) , was modified for use as the parental virus in these studies. This virus, originally TK-and resistant to AraT, was made TK+ and AraT-sensitive (AraTs) by rescue with the intact cloned TK gene (pRB103). Selection for the TK+ AraTs virus was performed in 143 cells in the presence of HAT medium (32) . The resultant virus, designated R5OBG13-1A1, will hereafter be called lAl. HSV-1(F) (8) and HSV-2(G) (8) were also used in these studies.
Plasmid and viral DNAs. The recombinant plasmids pRB103 [BamHI fragment Q of HSV-1(F) DNA cloned into pBR322] (31) and pRB309 (25) (described in Fig.  1 ) were provided by B. Roizman; pMG903 was generated as described in the legend to Fig. 1 11436 , specific for gD-1 (anti-gD-1); 111255 and 111114, both of which react with gD-1 and gD-2 (antigD-1/2); and 1173, specific for gC-1.
Sequential immunoprecipitations were performed on extracts prepared from infected HEp-2 cells. Labeled infected-cell monolayers were washed once in phosphate-buffered saline and lysed in extraction buffer consisting of 140 mM Tris-hydrochloride buffer (pH 7.4), 20 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, bovine serum albumin (1 mg/ml), and aprotinin (100 U/ml; Mobay Chemical Corp., New York, N.Y.). Cell extracts were cleared of nonsolubilized material by centrifugation at 178,000 x g in a Beckman airfuge. Cell extracts were mixed with an appropriate amount of antibody; after 30 min on ice, Formalin-fixed Staphylococcus auireuis (14) was added for 10 min, and immune complexes were collected by centrifugation. Antibody-treated supernatants from one reaction were usually mixed with a second aliquot of antibody, or with a different antibody, for second and subsequent rounds of immunoprecipitation. Precipitated proteins were eluted from S. auirelis after washing as described (16) and subjected to electrophoresis on 8.5% polyacrylamide gels linked with N,N'-diallyltartardiamide (10) . Fluorography was performed as described previously (15) .
Antibody-mediated neutralization of viral infectivity in the presence of complement was tested by a plaque reduction assay. Mixtures containing 500 PFU of the virus, the ascites form of the monoclonal antibody at a final concentration of either 1/50 or 1/500, and complement at a final concentration of 1/45 in 1 ml of total volume were incubated for 1 h at 37°C and then added to Vero cell monolayers as described (27) . Percent neutralized virus was calculated. Total transfection yields were assayed for the percentage of progeny expressing gD-1 by a slightly modified version (17) of a plaque immunoassay developed by Holland et al. (11) .
RESULTS
Selection and characterization of insertion mutants expressing gD-1 and gD-2. The procedure for construction of the insertion mutants is detailed above and in the legend to Fig. 1 Fig. 1 and the text for derivation of plasmids.
C Virus titrations were done on Vero cells in the absence and presence of AraT (100 pLg/ml). Titers in the absence of AraT ranged from 20 x 10' to 8.8 x 107 PFU/ml. Yields of some transfections were screened for gD-1 expression by the in situ plaque immunoassay mentioned in the text and described elsewhere (11, 17) . (Fig. 1) . All of the insertion mutants analyzed in this study replicated in HEp-2 cells to titers comparable to those obtained with the lAl strain, ) probe HSV-1(F), or HSV-2(G). There were no indica--J P-itions that replication of the mutants was in any ne structures of AraTr way impaired by the insertion. :ransfected with strain Processing of gD-1 and gD-2 by the insertion or pMG903. BamHI mutants. Pulse-chase experiments were perDNAs of the parental formed to compare the immature and mature solates (4-1, 3-3, 7-13), forms of gD-1 and gD-2 made by an insertion 17) were separated on mutant with those made by other HSV strains ioresis and transferred (Fig. 4) . Infected-cell extracts (pulse and pulsed 7-13 came from two chase) were sequentially and exhaustively pre-B309 DNA, whereas cipitated, first with anti-gD-i and then with antie'ction with pMG9O3 uences homologous to gD-1/2. The precursor and product forms of 309 (gD probe) were gD-1 produced by the insertion mutant 7-13 were the indicated labeled indistinguishable by electrophoresis from those made by HSV-1(F). Similarly, the precursor and product forms of gD-2 expressed by strain 7-13 could-not be distinguished from the gD-2 of lAl and HSV-2(G). As previously noted (3, 6, 23, 34) , both forms of gD-2 have slightly faster electrophoretic mobilities than those of gD-1.
Effects of a DNA synthesis inhibitor on gD-1 and gD-2 accumulation. To determine whether the amounts of gD-1 and gD-2 made or accumulated by the insertion mutants depended on viral DNA replication, cells were infected and labeled in the presence of phosphonoacetic acid (PAA), a specific inhibitor of herpesvirus DNA replication (22, 26) . Treatment of insertion mutantinfected cells (7) (8) (9) (10) (11) (12) (13) with PAA significantly reduced the amounts of gD-1 and gD-2 that accumulated as compared to untreated infected cells (Fig. 5) . The production of gD-1 by HSV-1(F) virus was also significantly inhibited by PAA, as was gD-2 production by HSV-2(G) virus. Similar findings were previously reported by Peake et al. (28) .
The late glycoprotein gC, immunoprecipitable by ascites fluid I173, was undetectable in PAAtreated cells infected with insertion mutant 3-3. Extracts of untreated and PAA-treated infected cells are presented in Fig. 5 to show the differential effects of PAA on accumulation of various viral proteins.
Transport of gD-1 to the infected-cell surface.
Lacto-peroxidase-catalyzed iodination of infected cells was performed to determine whether both gDs made by the insertion mutants were transported to the cell surface. Extracts of iodinated cells were sequentially immunoprecipitated as described. Analyses of these precipitates are presented in Fig. 6 . Insertion mutants 4-1 and 7-13 displayed both gD-1 and gD-2 on the cell surface, whereas 7-17, an AraTr gD- with no insertion, displayed only gD-2. The viruses lAl, HSV-1(F), and HSV-2(G) expressed either gD-1 or gD-2 only on infected-cell surfaces, as expected. Anti-gD-1 precipitated an additional iodinated protein of 125,000 daltons from viruses expressing gD-1. This high-molecular-weight material was not precipitable by antigB or anti-gC monoclonal antibodies (data not shown). It could be a dimeric form of gD-1, previously detected by Eisenberg et al. (7) . Alternatively, the iodination procedure could have induced cross-linking of gD-1 to other cell surface components.
Incorporation of gD into the virion.
[35S]methionine-labeled virions of the insertion mutant 7-13 were purified on Dextran T10 gradients to determine whether both gDs were incorporated into the viral envelope. Electrophoretic analysis of immunoprecipitates (Fig. 7) demonstrated that both gD-1 and gD-2 were present in the purified virion preparations of the insertion mutant. The parental virus lAl incorporated only gD-2 into the virion, as expected. Neutralization tests were done with selected insertion mutants to verify that gD-1 is on the virion surface and can serve as a target for immune recognition (Table 2 ). Viruses expressing both types of gD were neutralized by antigD-1 but not as efficiently as was HSV-1(F) virus, which expresses only gD-1. Although the extent of neutralization of insertion mutants and HSV-1(F) increased with increasing concentrations of anti-gD-1, it is unclear whether total neutralization might be achieved with this antibody under these conditions. Viruses expressing gD-1 alone, gD-2 alone, or both glycoproteins could be totally neutralized by anti-gD-1/2 at a dilution of 1/50. DISCUSSION We have isolated insertion mutants of HSV which contain two different forms of the gene for gD and express and utilize the products of both genes in a codominant fashion. These experi- Our results extend these findings and set the boundaries for any cis-acting sequences adjacent to the gD-1 coding sequence that might be necessary for the appropriate expression and regulation of gD-1 in the infected cell. Apparent- (16, 44) , also contains any necessary promoter and regulatory signals for gD-1 expression. Several pieces of evidence support this conclusion. First, gD-1 is expressed by the insertion mutants in equivalent amounts regardless of orientation of the Sacl fragment within the TK gene. Second, the inserted gene (regardless of its orientation) is apparently expressed under the same kind of control as is the gD-2 gene at the normal locus. Experiments with PAA showed a significant decrease in the amounts of both gD-1 and gD-2 produced by insertion mutants as well as by conventional viruses in the presence of the drug, whereas expression of TK, an early or ,B product, is enhanced under these conditions (9, 12, 18) . Therefore it seems likely that the 400-base-pair (bp) sequence upstream of the gD-1 mRNA initiation site (bounded on the left by a Sacl site; see Fig. 1 ) contains all promoter and regulatory signals necessary for expression of gD-1 under normal control in the infected cell. Mackem and Roizman (19) (20) (21) showed that regulatory signals influencing the expression of HSV a genes lie at least 110 to 140 bp upstream of the transcription initiation site and may even extend more than 330 bp upstream in some instances.
The 3' terminus of gD-1 mRNA lies 200 bp 3' to the Sacl site of the cloned gene (43, 44) and is therefore not contained in the sequences inserted into the TK gene. Transcription termination signals outside the Sacl fragment are presumably used for production of functional gD-1 mRNAs by the insertion mutants, as must be the case for the production of gC-1 mRNA by other insertion mutants (17) . Thus there appears to be no strict requirement with respect to sequence of nucleotides in the 3' noncoding region, at least for gD-1 and gC-1 mRNAs.
Several investigators have classified gD as an early or ,B polypeptide, based on its appearance by 2 h postinfection (1, 5) or its expression after a cycloheximide block or when DNA synthesis is inhibited (28) , or based on quantitation of gD mRNA accumulated in the presence of cytosine arabinoside, an inhibitor of DNA synthesis (44) . Our studies show that synthesis or accumulation of the gD polypeptide is significantly inhibited by PAA, a more effective inhibitor of viral DNA synthesis. Either gD is a late or y polypeptide according to the original definitions proposed (synthesis inhibited by the inhibition of viral DNA replication; see reference 12), or translation of the gD mRNA (if actually made in significant quantities when viral DNA replication is completely blocked) to yield a stable product requires a factor made under -y control.
The findings that both copies of the gD gene are expressed in the insertion mutants under apparently normal controls for this gene, and that both glycoprotein products appear in the cell surface and in virions, make the experimental system described here especially attractive for certain kinds of studies of HSV gene expression. Mutated forms of a glycoprotein gene can be inserted into the TK gene to assess effects of the mutations on expression of the gene and on synthesis, posttranslational processing, intracellular transport, and incorporation into cell membranes and virions. The effects of lethal mutations can be studied because the product expressed from the normal genetic locus can supply all essential functions. The results presented here and earlier (17, 25, 32, 33, 37) show that HSV can be a cloning vector useful for the isolation and study of particular HSV regulatory sequences, genes, and their products in the environment of the HSV-infected cell. The virus may also be a suitable cloning vector for the study of certain non-HSV genes.
